9th Circuit Ruling Sparks Legal Uncertainty in Cannabis Commerce
The 9th Circuit ruling creates cannabis commerce legal uncertainty by exempting cannabis from the dormant commerce clause. This decision allows states to impose protectionist cannabis regulations. Clinicians must navigate fragmented state cannabis…
IRS Disputes Cannabis Company’s Tax Argument (Newsletter: March 12, 2026)
Cannabis companies tax disputes with the IRS create financial uncertainty that may affect product pricing and availability for patients who depend on medical cannabis. The ongoing tax disputes highlight federal barriers to cannabis industry legitimacy…
After Federal Court Win, Oklahoma Medical Marijuana Operators Fight State
Oklahoma medical marijuana legal challenges have intensified after a federal court victory for operators. These legal disputes focus on state regulatory overreach affecting patient access. Clinicians should monitor these developments as they impact the…
How Rescheduling Will Impact Cannabis Intellectual Property Valuations
Cannabis intellectual property valuation will significantly shift following federal rescheduling, reshaping medical cannabis operators' asset pricing. This change primarily impacts pharmaceutical-grade cannabis products developed under strict research…
How Federal Rescheduling Could Influence Tennessee Medical Cannabis Legalization
Tennessee medical cannabis legalization prospects are evolving with federal rescheduling discussions. This shift could allow clinicians to recommend cannabis legally, expanding treatment options. Tennessee healthcare providers should stay informed about…
Federal Law Bars Workers Compensation Coverage for Medical Marijuana Use
Federal workers compensation cannabis coverage is prohibited under federal law, despite state medical marijuana programs. Injured workers may face out-of-pocket costs for cannabis treatments. Clinicians should counsel patients on insurance limitations…
In the Mix: 9 More Articles — March 11, 2026
This article reviews cannabis market consolidation and clinical trends in 2026. It highlights regulatory developments and CBD products for pain management. Cannabis market consolidation is shaping clinical applications and governance.
In the Mix: 7 More Articles — March 10, 2026
This update covers the cannabis research funding landscape and its impact on clinical and regulatory developments. Market expansion into minor cannabinoids and retail normalization are key themes. Enforcement patterns and psychoactive substance…
Federal Marijuana Rescheduling May Speed Tennessee MMJ Legalization
Federal marijuana rescheduling Tennessee medical cannabis could remove barriers to clinical research and accelerate legalization in Tennessee. This shift allows clinicians to access evidence-based data for patient care. It also enables a legal framework…
In the Mix: 5 More Articles — March 07, 2026
This article reviews cannabis industry regulatory challenges including enforcement actions and roadside THC testing accuracy. It covers hemp product regulation and retail expansion trends. These topics highlight evolving cannabis policy enforcement in…